Do analysts recommend AVNS or SNAL?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Avanos Medical 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 Snail 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 2.67

Is AVNS or SNAL more profitable?

Avanos Medical has a net margin of -10.39% compared to Snail's net margin of -11.73%. Avanos Medical's return on equity of 5.39% beat Snail's return on equity. Company Net Margins Return on Equity Return on Assets Avanos Medical -10.39% 5.39% 3.97% Snail -11.73% -15.49% 5.24%

Does the media favor AVNS or SNAL?

In the previous week, Snail had 2 more articles in the media than Avanos Medical. MarketBeat recorded 8 mentions for Snail and 6 mentions for Avanos Medical. Avanos Medical's average media sentiment score of 1.00 beat Snail's score of 0.33 indicating that Avanos Medical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Avanos Medical 4 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Snail 2 Very Positive mention(s) 0 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts rate AVNS or NVST?

Envista has a consensus price target of $29.31, suggesting a potential upside of 3.86%. Given Envista's stronger consensus rating and higher possible upside, analysts clearly believe Envista is more favorable than Avanos Medical. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Avanos Medical 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 Envista 0 Sell rating(s) 10 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.38

Which has stronger valuation and earnings, AVNS or NVST?

Envista has higher revenue and earnings than Avanos Medical. Avanos Medical is trading at a lower price-to-earnings ratio than Envista, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Avanos Medical $715.90M 1.64 -$72.90M -$1.61 N/A Envista $2.72B 1.67 $47M $0.58 48.65

Does the media favor AVNS or NVST?

In the previous week, Envista had 12 more articles in the media than Avanos Medical. MarketBeat recorded 18 mentions for Envista and 6 mentions for Avanos Medical. Avanos Medical's average media sentiment score of 1.00 beat Envista's score of 0.69 indicating that Avanos Medical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Avanos Medical 4 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Envista 5 Very Positive mention(s) 2 Positive mention(s) 8 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts prefer ICUI or AVNS?

ICU Medical presently has a consensus target price of $192.80, suggesting a potential upside of 4.46%. Given ICU Medical's stronger consensus rating and higher probable upside, equities analysts clearly believe ICU Medical is more favorable than Avanos Medical. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score ICU Medical 0 Sell rating(s) 3 Hold rating(s) 4 Buy rating(s) 2 Strong Buy rating(s) 2.89 Avanos Medical 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50

Does the media refer more to ICUI or AVNS?

In the previous week, ICU Medical had 22 more articles in the media than Avanos Medical. MarketBeat recorded 28 mentions for ICU Medical and 6 mentions for Avanos Medical. Avanos Medical's average media sentiment score of 1.00 beat ICU Medical's score of 0.90 indicating that Avanos Medical is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment ICU Medical 13 Very Positive mention(s) 4 Positive mention(s) 7 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Avanos Medical 4 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts prefer XRAY or AVNS?

DENTSPLY SIRONA currently has a consensus price target of $13.54, suggesting a potential upside of 11.70%. Given DENTSPLY SIRONA's stronger consensus rating and higher possible upside, equities research analysts clearly believe DENTSPLY SIRONA is more favorable than Avanos Medical. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score DENTSPLY SIRONA 3 Sell rating(s) 9 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.00 Avanos Medical 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50

Does the media refer more to XRAY or AVNS?

In the previous week, DENTSPLY SIRONA had 16 more articles in the media than Avanos Medical. MarketBeat recorded 22 mentions for DENTSPLY SIRONA and 6 mentions for Avanos Medical. Avanos Medical's average media sentiment score of 1.00 beat DENTSPLY SIRONA's score of 0.52 indicating that Avanos Medical is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment DENTSPLY SIRONA 7 Very Positive mention(s) 1 Positive mention(s) 10 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive Avanos Medical 4 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts rate AVNS or NEOG?

Neogen has a consensus target price of $11.67, indicating a potential upside of 1.71%. Given Neogen's stronger consensus rating and higher possible upside, analysts clearly believe Neogen is more favorable than Avanos Medical. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Avanos Medical 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 Neogen 1 Sell rating(s) 3 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.17

Which has better valuation and earnings, AVNS or NEOG?

Neogen has higher revenue and earnings than Avanos Medical. Neogen is trading at a lower price-to-earnings ratio than Avanos Medical, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Avanos Medical $715.90M 1.64 -$72.90M -$1.61 N/A Neogen $870.40M 2.87 -$7.90M -$0.03 N/A

Is AVNS or NEOG more profitable?

Neogen has a net margin of -0.91% compared to Avanos Medical's net margin of -10.39%. Avanos Medical's return on equity of 5.39% beat Neogen's return on equity. Company Net Margins Return on Equity Return on Assets Avanos Medical -10.39% 5.39% 3.97% Neogen -0.91% 2.78% 1.74%

Does the media prefer AVNS or NEOG?

In the previous week, Avanos Medical had 2 more articles in the media than Neogen. MarketBeat recorded 6 mentions for Avanos Medical and 4 mentions for Neogen. Avanos Medical's average media sentiment score of 1.00 beat Neogen's score of 0.84 indicating that Avanos Medical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Avanos Medical 4 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Neogen 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Avanos Medical (AVNS) Competitors

$24.99 0.00 (0.00%)

As of 08/7/2026

Compare

AVNS vs. SNAL, NVST, ICUI, XRAY, and NEOG

Should you buy Avanos Medical stock or one of its competitors? MarketBeat compares Avanos Medical with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Avanos Medical include Snail (SNAL), Envista (NVST), ICU Medical (ICUI), DENTSPLY SIRONA (XRAY), and Neogen (NEOG).

How does Avanos Medical compare to Snail?

Avanos Medical (NYSE:AVNS) and Snail (NASDAQ:SNAL) are related small-cap companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, profitability, valuation, analyst recommendations, media sentiment, risk, institutional ownership and dividends.

Avanos Medical has a net margin of -10.39% compared to Snail's net margin of -11.73%. Avanos Medical's return on equity of 5.39% beat Snail's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Avanos Medical	-10.39%	5.39%	3.97%
Snail	-11.73%	-15.49%	5.24%

95.2% of Avanos Medical shares are held by institutional investors. Comparatively, 0.4% of Snail shares are held by institutional investors. 2.3% of Avanos Medical shares are held by company insiders. Comparatively, 66.8% of Snail shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Avanos Medical	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
Snail	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.67

In the previous week, Snail had 2 more articles in the media than Avanos Medical. MarketBeat recorded 8 mentions for Snail and 6 mentions for Avanos Medical. Avanos Medical's average media sentiment score of 1.00 beat Snail's score of 0.33 indicating that Avanos Medical is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Avanos Medical	4 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Snail	2 Very Positive mention(s)	0 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Snail has lower revenue, but higher earnings than Avanos Medical. Avanos Medical is trading at a lower price-to-earnings ratio than Snail, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Avanos Medical	$715.90M	1.64	-$72.90M	-$1.61	N/A
Snail	$88.41M	0.46	-$27.24M	-$3.10	N/A

Avanos Medical has a beta of 1.57, indicating that its share price is 57% more volatile than the broader market. Comparatively, Snail has a beta of 1.29, indicating that its share price is 29% more volatile than the broader market.

Summary

Avanos Medical and Snail tied by winning 8 of the 16 factors compared between the two stocks.

How does Avanos Medical compare to Envista?

Avanos Medical (NYSE:AVNS) and Envista (NYSE:NVST) are both healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their media sentiment, profitability, valuation, institutional ownership, analyst recommendations, earnings, risk and dividends.

In the previous week, Envista had 12 more articles in the media than Avanos Medical. MarketBeat recorded 18 mentions for Envista and 6 mentions for Avanos Medical. Avanos Medical's average media sentiment score of 1.00 beat Envista's score of 0.69 indicating that Avanos Medical is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Avanos Medical	4 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Envista	5 Very Positive mention(s)	2 Positive mention(s)	8 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Envista has higher revenue and earnings than Avanos Medical. Avanos Medical is trading at a lower price-to-earnings ratio than Envista, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Avanos Medical	$715.90M	1.64	-$72.90M	-$1.61	N/A
Envista	$2.72B	1.67	$47M	$0.58	48.65

Envista has a consensus price target of $29.31, suggesting a potential upside of 3.86%. Given Envista's stronger consensus rating and higher possible upside, analysts clearly believe Envista is more favorable than Avanos Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Avanos Medical	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
Envista	0 Sell rating(s)	10 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.38

Envista has a net margin of 3.33% compared to Avanos Medical's net margin of -10.39%. Envista's return on equity of 7.88% beat Avanos Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Avanos Medical	-10.39%	5.39%	3.97%
Envista	3.33%	7.88%	4.33%

95.2% of Avanos Medical shares are owned by institutional investors. 2.3% of Avanos Medical shares are owned by insiders. Comparatively, 1.0% of Envista shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Avanos Medical has a beta of 1.57, indicating that its share price is 57% more volatile than the broader market. Comparatively, Envista has a beta of 0.86, indicating that its share price is 14% less volatile than the broader market.

Summary

Envista beats Avanos Medical on 12 of the 16 factors compared between the two stocks.

How does Avanos Medical compare to ICU Medical?

ICU Medical (NASDAQ:ICUI) and Avanos Medical (NYSE:AVNS) are both healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, analyst recommendations, valuation, profitability, media sentiment, risk, dividends and earnings.

ICU Medical has a net margin of 1.39% compared to Avanos Medical's net margin of -10.39%. ICU Medical's return on equity of 7.91% beat Avanos Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
ICU Medical	1.39%	7.91%	4.17%
Avanos Medical	-10.39%	5.39%	3.97%

96.1% of ICU Medical shares are held by institutional investors. Comparatively, 95.2% of Avanos Medical shares are held by institutional investors. 2.1% of ICU Medical shares are held by insiders. Comparatively, 2.3% of Avanos Medical shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

ICU Medical presently has a consensus target price of $192.80, suggesting a potential upside of 4.46%. Given ICU Medical's stronger consensus rating and higher probable upside, equities analysts clearly believe ICU Medical is more favorable than Avanos Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
ICU Medical	0 Sell rating(s)	3 Hold rating(s)	4 Buy rating(s)	2 Strong Buy rating(s)	2.89
Avanos Medical	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

In the previous week, ICU Medical had 22 more articles in the media than Avanos Medical. MarketBeat recorded 28 mentions for ICU Medical and 6 mentions for Avanos Medical. Avanos Medical's average media sentiment score of 1.00 beat ICU Medical's score of 0.90 indicating that Avanos Medical is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
ICU Medical	13 Very Positive mention(s)	4 Positive mention(s)	7 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Avanos Medical	4 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

ICU Medical has higher revenue and earnings than Avanos Medical. Avanos Medical is trading at a lower price-to-earnings ratio than ICU Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
ICU Medical	$2.23B	2.07	$730K	$1.85	99.76
Avanos Medical	$715.90M	1.64	-$72.90M	-$1.61	N/A

ICU Medical has a beta of 0.74, meaning that its share price is 26% less volatile than the broader market. Comparatively, Avanos Medical has a beta of 1.57, meaning that its share price is 57% more volatile than the broader market.

Summary

ICU Medical beats Avanos Medical on 14 of the 17 factors compared between the two stocks.

How does Avanos Medical compare to DENTSPLY SIRONA?

DENTSPLY SIRONA (NASDAQ:XRAY) and Avanos Medical (NYSE:AVNS) are both healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, media sentiment, analyst recommendations, dividends, profitability, valuation, risk and earnings.

Avanos Medical has lower revenue, but higher earnings than DENTSPLY SIRONA. Avanos Medical is trading at a lower price-to-earnings ratio than DENTSPLY SIRONA, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
DENTSPLY SIRONA	$3.68B	0.66	-$598M	-$2.75	N/A
Avanos Medical	$715.90M	1.64	-$72.90M	-$1.61	N/A

DENTSPLY SIRONA has a beta of 0.85, meaning that its share price is 15% less volatile than the broader market. Comparatively, Avanos Medical has a beta of 1.57, meaning that its share price is 57% more volatile than the broader market.

In the previous week, DENTSPLY SIRONA had 16 more articles in the media than Avanos Medical. MarketBeat recorded 22 mentions for DENTSPLY SIRONA and 6 mentions for Avanos Medical. Avanos Medical's average media sentiment score of 1.00 beat DENTSPLY SIRONA's score of 0.52 indicating that Avanos Medical is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
DENTSPLY SIRONA	7 Very Positive mention(s)	1 Positive mention(s)	10 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive
Avanos Medical	4 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

95.7% of DENTSPLY SIRONA shares are held by institutional investors. Comparatively, 95.2% of Avanos Medical shares are held by institutional investors. 0.5% of DENTSPLY SIRONA shares are held by company insiders. Comparatively, 2.3% of Avanos Medical shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

DENTSPLY SIRONA currently has a consensus price target of $13.54, suggesting a potential upside of 11.70%. Given DENTSPLY SIRONA's stronger consensus rating and higher possible upside, equities research analysts clearly believe DENTSPLY SIRONA is more favorable than Avanos Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
DENTSPLY SIRONA	3 Sell rating(s)	9 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.00
Avanos Medical	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

Avanos Medical has a net margin of -10.39% compared to DENTSPLY SIRONA's net margin of -14.99%. DENTSPLY SIRONA's return on equity of 20.84% beat Avanos Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
DENTSPLY SIRONA	-14.99%	20.84%	5.32%
Avanos Medical	-10.39%	5.39%	3.97%

Summary

DENTSPLY SIRONA beats Avanos Medical on 9 of the 16 factors compared between the two stocks.

How does Avanos Medical compare to Neogen?

Avanos Medical (NYSE:AVNS) and Neogen (NASDAQ:NEOG) are both healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, media sentiment, valuation, earnings, analyst recommendations, dividends, institutional ownership and risk.

In the previous week, Avanos Medical had 2 more articles in the media than Neogen. MarketBeat recorded 6 mentions for Avanos Medical and 4 mentions for Neogen. Avanos Medical's average media sentiment score of 1.00 beat Neogen's score of 0.84 indicating that Avanos Medical is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Avanos Medical	4 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Neogen	1 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Avanos Medical has a beta of 1.57, suggesting that its share price is 57% more volatile than the broader market. Comparatively, Neogen has a beta of 1.76, suggesting that its share price is 76% more volatile than the broader market.

95.2% of Avanos Medical shares are owned by institutional investors. Comparatively, 96.7% of Neogen shares are owned by institutional investors. 2.3% of Avanos Medical shares are owned by insiders. Comparatively, 0.6% of Neogen shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Neogen has a net margin of -0.91% compared to Avanos Medical's net margin of -10.39%. Avanos Medical's return on equity of 5.39% beat Neogen's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Avanos Medical	-10.39%	5.39%	3.97%
Neogen	-0.91%	2.78%	1.74%

Neogen has higher revenue and earnings than Avanos Medical. Neogen is trading at a lower price-to-earnings ratio than Avanos Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Avanos Medical	$715.90M	1.64	-$72.90M	-$1.61	N/A
Neogen	$870.40M	2.87	-$7.90M	-$0.03	N/A

Neogen has a consensus target price of $11.67, indicating a potential upside of 1.71%. Given Neogen's stronger consensus rating and higher possible upside, analysts clearly believe Neogen is more favorable than Avanos Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Avanos Medical	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
Neogen	1 Sell rating(s)	3 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.17

Summary

Neogen beats Avanos Medical on 10 of the 16 factors compared between the two stocks.

Get Avanos Medical News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AVNS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

AVNS vs. The Competition

Export

Metric	Avanos Medical	Healthcare Equipment & Supplies Industry	Healthcare Sector	NYSE Exchange
Market Cap	$1.17B	$5.86B	$7.02B	$24.18B
Dividend Yield	N/A	1.78%	2.58%	3.69%
P/E Ratio	-15.52	24.26	270.57	29.14
Price / Sales	1.64	68.31	599.88	19.19
Price / Cash	7.30	33.55	28.89	19.37
Price / Book	1.49	6.11	11.21	4.91
Net Income	-$72.90M	$149.01M	$3.45B	$1.06B
7 Day Performance	N/A	4.75%	4.67%	2.91%
1 Month Performance	0.24%	0.71%	-1.28%	2.94%
1 Year Performance	131.93%	4.93%	77.33%	20.40%

Avanos Medical Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
AVNS Avanos Medical	1.263 of 5 stars	$24.99 flat	N/A	N/A	$1.17B	$715.90M	N/A	2,287	News Coverage Upcoming Earnings
SNAL Snail	2.5603 of 5 stars	$4.07 -1.9%	N/A	-2.6%	$34.86M	$88.41M	N/A	60	Upcoming Earnings
NVST Envista	2.3072 of 5 stars	$27.59 +0.8%	$28.62 +3.7%	+39.2%	$4.49B	$2.72B	67.27	12,000	News Coverage Positive News Earnings Report Analyst Forecast
ICUI ICU Medical	2.863 of 5 stars	$170.76 -1.3%	$172.00 +0.7%	+63.5%	$4.27B	$2.16B	92.26	13,000	Trending News Earnings Report Analyst Forecast Gap Up
XRAY DENTSPLY SIRONA	3.4171 of 5 stars	$14.22 +0.6%	$13.46 -5.3%	-6.5%	$2.86B	$3.68B	N/A	14,000	Trending News Earnings Report Analyst Forecast

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:AVNS) was last updated on 8/9/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Avanos Medical (AVNS) Competitors

AVNS vs. SNAL, NVST, ICUI, XRAY, and NEOG

How does Avanos Medical compare to Snail?

Summary

How does Avanos Medical compare to Envista?

Summary

How does Avanos Medical compare to ICU Medical?

Summary

How does Avanos Medical compare to DENTSPLY SIRONA?

Summary

How does Avanos Medical compare to Neogen?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

AVNS vs. The Competition

Avanos Medical Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Avanos Medical (AVNS) Competitors

AVNS vs. SNAL, NVST, ICUI, XRAY, and NEOG

How does Avanos Medical compare to Snail?

Is AVNS or SNAL more profitable?

Do institutionals & insiders believe in AVNS or SNAL?

Do analysts recommend AVNS or SNAL?

Does the media favor AVNS or SNAL?

Which has higher valuation and earnings, AVNS or SNAL?

Which has more risk & volatility, AVNS or SNAL?

Summary

How does Avanos Medical compare to Envista?

Does the media favor AVNS or NVST?

Which has stronger valuation and earnings, AVNS or NVST?

Do analysts rate AVNS or NVST?

Is AVNS or NVST more profitable?

Do insiders & institutionals believe in AVNS or NVST?

Which has more risk and volatility, AVNS or NVST?

Summary

How does Avanos Medical compare to ICU Medical?

Is ICUI or AVNS more profitable?

Do institutionals and insiders believe in ICUI or AVNS?

Do analysts prefer ICUI or AVNS?

Does the media refer more to ICUI or AVNS?

Which has higher valuation and earnings, ICUI or AVNS?

Which has more volatility & risk, ICUI or AVNS?

Summary

How does Avanos Medical compare to DENTSPLY SIRONA?

Which has preferable earnings & valuation, XRAY or AVNS?

Which has more volatility and risk, XRAY or AVNS?

Does the media refer more to XRAY or AVNS?

Do institutionals & insiders believe in XRAY or AVNS?

Do analysts prefer XRAY or AVNS?

Is XRAY or AVNS more profitable?

Summary

How does Avanos Medical compare to Neogen?

Does the media prefer AVNS or NEOG?

Which has more risk and volatility, AVNS or NEOG?

Do insiders & institutionals believe in AVNS or NEOG?

Is AVNS or NEOG more profitable?

Which has better valuation and earnings, AVNS or NEOG?

Do analysts rate AVNS or NEOG?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

AVNS vs. The Competition

Avanos Medical Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools